Introduction
============

Presbyopia is an age-related gradual, progressive loss of accommodation with recession of the near point of distinct vision over time. The eye is no longer able to either exert or maintain the accommodation required for clear near vision, necessitating the use of spectacles to enable the patient to see near distance. Intermediate vision, as well, might get affected with time.

Surgical techniques for presbyopia correction are diverse. However, they can be classified into two main approaches based on the mechanism of near vision restoration. The first approach aims at restoration of the eye's true accommodative ability, such as anterior ciliary sclerotomy,[@b1-opth-5-1525] scleral expansion,[@b2-opth-5-1525] and accommodative intraocular lenses (IOLs).[@b3-opth-5-1525] The second approach includes restoration of helpful near vision without true gains in the eye's accommodation by means of increasing the depth of focus, that is, pseudoaccommodation. Pseudoaccommodation can be achieved through either corneal techniques or intraocular surgery such as multifocal IOLs.[@b4-opth-5-1525],[@b5-opth-5-1525] Monovision[@b6-opth-5-1525] is another option that can be achieved via conductive keratoplasty,[@b7-opth-5-1525] excimer laser, or monofocal IOLs.

In 2007, the authors performed an eventless wavefront-guided laser-assisted in situ keratomileusis on a 45-year-old male for moderate myopia. Postoperatively, he was able to see 20/15 unaided. Follow-up wavefront examinations revealed the accidental induction of a huge amount of vertical coma corresponding to an area of minimal ablation decentration on topography. Interestingly, this patient's distance corrected near acuity (DCNA) improved from 20/70 preoperatively to 20/20 after the procedure.

Based on this observation and the fact that not all aberrations are harmful,[@b8-opth-5-1525] this prospective study evaluated the possibility of improving near vision in presbyopic patients with low to moderate myopia through selective treatment of high-order aberrations (HOAs).

Patients and methods
====================

This prospective consecutive comparative randomized double-masked study was carried out at Horus Vision Correction Center in Alexandria, Egypt, from January to July 2009. Written informed consent was obtained from the patients before their participation in the study.

Patient selection
-----------------

Fifty-two eyes of 26 patients, all aged \>40 years, with symptoms of presbyopia were included in this study. Exclusion criteria were: \<40 years old, any abnormal or suspicious patterns on corneal topography, central pachymetric measurements \<500 μm, and history of chronic eye diseases. Patients with lens opacities were also excluded from the study.

Included patients all had low to moderate myopia with best corrected distance visual acuity (BCVA) of 20/20 for distance. All patients had total coma aberration of \>0.2 μm at 6.0 mm pupil diameter. They were randomly divided into two groups, A and B.

In Group A, all HOAs were treated along with the sphere and cylinder. This group included 30 eyes of 15 patients (9 females and 6 males), with a mean age of 47.46 years (range 43--51 years). Mean manifest refraction spherical equivalent (MRSE) was −2.37 D (range −1.75 to −4.0 D) and mean total root mean square (RMS) value was 0.35 μm (range 0.26--0.53 μm).

In Group B, vertical coma aberrations were selectively left untreated, while all other HOAs, along with the sphere and cylinder, were treated. This group included 22 eyes of 11 patients (8 females and 3 males) with a mean age of 45.2 years (range 42--50 years). Mean MRSE was −2.87 D (range −2.0 to −4.5 D) and mean total RMS value was 0.38 μm (range 0.28--0.56 μm). [Table 1](#t1-opth-5-1525){ref-type="table"} shows the preoperative data of the two groups in terms of age, sex, MRSE, and root mean square RMS.

Preoperative evaluation
-----------------------

All patients were tested for uncorrected distance visual acuity (UCVA), manifest and cycloplejic refractions, and BCVA. Near vision capabilities were also determined at a distance of 40 cm by testing uncorrected near acuity (UCNA), best corrected near acuity with addition for near vision (BCNA), and DCNA.

All patients were subjected to corneal mapping using the Humphrey^®^ Atlas™ 993 (Carl Zeiss Meditech, Inc, Dublin, CA) Placido-disk corneal topographer, corneal pachymetry, pupil diameter measurement, contrast sensitivity testing using the CSV-1000E (VectorVision, Inc, Greenville, OH) chart, and a detailed slit-lamp examination using the Haag-Streit BM 900 slit-lamp (Haag-Streit International, Bern, Switzerland). ORK-CAM (SCHWIND eye-tech-solutions, Kleinostheim, Germany) software was used for all patients to measure HOAs and design ocular wavefront-guided treatment.

All HOAs were treated in Group A along with the sphere and cylinder, while vertical coma aberrations were left untreated in Group B.

Surgical technique
------------------

All patients had laser-assisted in situ keratomileusis done using the Moria M2 (Moria, Antony, France) mechanical microkeratome for flap creation. A flap diameter of 9.5 mm and thickness of 130 μm were intended. Wavefront-guided treatment was performed in both groups using the SCHWIND ESIRIS (SCHWIND eye-tech-solutions) excimer laser platform. [Figure 1](#f1-opth-5-1525){ref-type="fig"} shows a wavefront map in a patient pre-and postoperatively.

Follow-up and data analysis
---------------------------

Double-masked postoperative follow-up visits were scheduled at 1 day, 1 week, 1 month, and 3 months. The evaluation included measurement of distance UCVA and BCVA, manifest refraction, near UCVA, BCVA, and DCNA. Corneal topography, contrast sensitivity, and aberrometry were done at 1 and 3 months.

Statistical analysis was performed using the Microsoft Excel 2003 (Microsoft Corp, Redmond, WA) Data Analysis Tool Pak. Paired Student's *t*-test was applied to compare data means.

Results
=======

Safety
------

Safety index of the procedure (ratio of postoperative BCVA to preoperative BCVA) at 3 months was 1.0 and 1.1 for groups A and B, respectively, with no significant change in the postoperative BCVA compared with preoperative levels. Similarly, the difference in postoperative BCVA at 3 months between both groups was statistically insignificant ([Figure 2](#f2-opth-5-1525){ref-type="fig"}).

Efficacy
--------

UCVA significantly improved at 1 and 3 months postoperatively in both groups ([Figure 3](#f3-opth-5-1525){ref-type="fig"}). All cases in both groups achieved a UCVA of 20/30 or better.

Predictability
--------------

In Groups A and B, 80% and 70%, respectively, of cases were within ±0.5 D of emmetropia at 3 months. All cases in both groups were within 1.0 D of emmetropia. ([Figure 4](#f4-opth-5-1525){ref-type="fig"}.)

Near visual acuity
------------------

BCNA showed no statistically significant differences at 3 months after the procedure in both groups compared with preoperative levels. Similarly, the difference between both groups in postoperative BCNA at 3 months was statistically insignificant ([Figure 5](#f5-opth-5-1525){ref-type="fig"}). UCNA in Group B was significantly better than in Group A patients (*P* \< 0.001) ([Figure 6](#f6-opth-5-1525){ref-type="fig"}).

In Group B patients at 3 months after the procedure, DCNA was significantly improved compared with preoperative levels, while negligible difference was recorded in Group A. Postoperative DCNA was significantly better in Group B compared with Group A patients. ([Figure 7](#f7-opth-5-1525){ref-type="fig"}.)

HOAs and contrast sensitivity
-----------------------------

Three months after the operations, vertical coma was significantly higher in Group B compared with Group A (*P* \< 0.003). Other aberrations did not show statistically significant differences between the two groups in the postoperative period ([Figure 8](#f8-opth-5-1525){ref-type="fig"}).

With regard to the comparison of different HOAs pre- and postoperatively, there was no significant difference, in each group, between pre- and postoperative values except in the vertical coma of Group B, which showed significant increase at 3 months postoperatively (*P* \< 0.05). Contrast sensitivity significantly improved in both groups after the procedure ([Figure 9](#f9-opth-5-1525){ref-type="fig"}). No significant intergroup contrast sensitivity differences were detected in the postoperative period.

Discussion
==========

Presbyopia correction is one of the most challenging situations in refractive surgery and ophthalmology. The challenges come from the fact that full understanding of accommodation and pathophysiology of presbyopia has not yet been reached. At the same time, presbyopia is the only refractive error that continues to progress with time.

The effect of wavefront aberrations on the quality of vision is quite obvious and several studies have attributed specific visual symptoms to specific types of HOAs. Chalita et al[@b8-opth-5-1525] showed positive correlation of double vision with total coma and with horizontal coma for the 5 mm and 7 mm pupil sizes, negative correlation between starburst and total coma for the 7 mm pupil size, positive correlation of double vision with horizontal coma, and glare and starburst with spherical aberration and with total aberrations. Melamud et al[@b9-opth-5-1525] showed that horizontal and vertical coma might be responsible for horizontal and vertical diplopia in symptomatic patients.

Just like all other aberrations, average normal values of coma aberrations vary depending on the pupil size but generally should be approximately 0.35 μm for a 7.0 mm[@b10-opth-5-1525] and 0.28 μm for 6.0 mm pupil diameter.[@b11-opth-5-1525]

The authors are unaware of any studies that have correlated vertical coma with near vision abilities. It is assumed that vertical coma at certain magnitudes could improve near vision potentials of the eye through increasing the depth of focus. However, to be established, this assumption needs a larger number of cases with longer follow-up periods.
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![Wavefront map of a patient in Group B before (**A**) and after (**B**) treatment, showing an almost stable amount of vertical coma.](opth-5-1525f1){#f1-opth-5-1525}

![Safety: preoperative (pre-op) versus postoperative (post-op) best corrected visual acuity.](opth-5-1525f2){#f2-opth-5-1525}

![Efficacy: postoperative (post-op) uncorrected distance visual acuity versus preoperative (pre-op) best corrected visual acuity.](opth-5-1525f3){#f3-opth-5-1525}

![Predictability; the percent of eyes within ±0.5 D and ±1.0 D of emmetropia at 3 months.](opth-5-1525f4){#f4-opth-5-1525}

![Preoperative (pre-op) and postoperative (post-op) best corrected near acuity with addition for near vision of both groups with the suitable addition showing no significant difference between both groups either pre- or postoperatively.](opth-5-1525f5){#f5-opth-5-1525}

![Preoperative (pre-op) and postoperative (post-op) uncorrected near acuity showing no preoperative significant difference between both groups and significant difference postoperatively.](opth-5-1525f6){#f6-opth-5-1525}

![Preoperative (pre-op) and postoperative (post-op) distance corrected near acuity showing no preoperative significant difference between both groups and significant difference postoperatively.](opth-5-1525f7){#f7-opth-5-1525}

![Postoperative high-order aberrations (HOAs) showing no significant difference between both groups except in vertical coma, which was significantly higher in Group B than Group A.](opth-5-1525f8){#f8-opth-5-1525}

![Contrast sensitivity shows no significant difference between groups A and B either preoperatively (pre-op) or postoperatively (post-op).](opth-5-1525f9){#f9-opth-5-1525}

###### 

Preoperative data showing no significant difference between both groups in terms of age, sex, manifest refractive spherical equivalent (MRSE), and root mean square (RMS)

  Group         A                               B
  ------------- ------------------------------- -------------------------------------
  No of eyes    30                              22
  Age (years)   47.46 (range 43--51)            45.2 (range 42--50)
  Sex           9 females, 6 males              8 females, 3 males
  MRSE          −2.37 D (range −1.75 to −4.0)   2.87 D −2.87 D (range −2.0 to −4.5)
  RMS           0.35 μm (range 0.26--0.53)      0.38 μm (range 0.28--0.56)
